Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03122665Phase 1Completed
Phase 1, randomised, double-blind trial of nefopam (2 arms), sponsored by Cleveland Clinic. Primary endpoints: Volume of distribution of the central compartment at 3 hours, Volume of distribution of the peripheral compartment at 3 hours and 2 more. Started Aug 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03122665.